Effects and tolerability of exercise therapy modality on cardiorespiratory fitness in lung cancer: a randomized controlled trial

被引:31
作者
Scott, Jessica M. [1 ,2 ]
Thomas, Samantha M. [3 ]
Herndon, James E. [3 ]
Douglas, Pamela S. [3 ]
Yu, Anthony F. [1 ,2 ]
Rusch, Valerie [1 ,2 ]
Huang, James [1 ,2 ]
Capaci, Catherine [1 ]
Harrison, Jenna N. [1 ]
Stoeckel, Kurtis J. [1 ]
Nilsen, Tormod [4 ]
Edvardsen, Elisabeth [4 ]
Michalski, Meghan G. [1 ]
Eves, Neil D. [5 ]
Jones, Lee W. [1 ,2 ]
机构
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Weill Cornell Med Coll, New York, NY 10065 USA
[3] Duke Univ, Med Ctr, Durham, NC USA
[4] Norwegian Sch Sport Sci, Dept Sports Med, Oslo, Norway
[5] Univ British Columbia, Kelowna, BC, Canada
基金
美国国家卫生研究院;
关键词
Aerobic training; Resistance training; Combination training; Exercise capacity; Cancer survivorship; QUALITY-OF-LIFE; CARDIOPULMONARY FUNCTION; FUNCTIONAL ASSESSMENT; OXYGEN-CONSUMPTION; INTENSITY; RESECTION; CAPACITY; STRENGTH; SURGERY; REHABILITATION;
D O I
10.1002/jcsm.12828
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background Poor cardiorespiratory fitness (CRF) is a cardinal feature of post-treatment primary lung cancer. The most effective exercise therapy regimen to improve CRF has not been determined. Methods In this parallel-group factorial randomized controlled trial, lung cancer survivors with poor CRF (below age-sex sedentary values) were randomly allocated to receive 48 consecutive supervised sessions thrice weekly of (i) aerobic training (AT)-cycle ergometry at 55% to >95% of peak oxygen consumption (VO(2)peak); (ii) resistance training (RT)-lower and upper extremity exercises at 50-85% of maximal strength; (iii) combination training (CT)-AT plus RT; or (iv) stretching attention control (AC) for 16 weeks. The primary endpoint was change in CRF (VO(2)peak, mL O-2 center dot kg(-1)center dot min(-1)). Secondary endpoints were body composition, muscle strength, patient-reported outcomes, tolerability (relative dose intensity of exercise), and safety. Analysis of covariance determined change in primary and secondary endpoints from baseline to post-intervention (Week 17) with adjustment for baseline values of the endpoint and other relevant clinical covariates. Results Ninety patients (65 +/- 9 years; 66% female) were randomized (AT, n = 24; RT, n = 23; CT, n = 20; and AC, n = 23) of the planned n = 160. No serious adverse events were observed. For the overall cohort, the lost-to-follow-up rate was 10%. Mean attendance was >= 75% in all groups. In intention-to-treat analysis, VO(2)peak increased 1.1 mL O-2 center dot kg(-1)center dot min(-1) [95% confidence interval (CI): 0.0, 2.2, P = 0.04] and 1.4 mL O-2 center dot kg(-1)center dot min(-1) (95% CI: 0.2, 2.5, P = 0.02) in AT and CT, respectively, compared with AC. There was no difference in VO(2)peak change between RT and AC (-0.1 mL O-2 center dot kg(-1)center dot min(-1), 95% CI: -1.2, 1.0, P = 0.88). Favourable improvements in maximal strength and body composition were observed in RT and CT groups compared with AT and AC groups (Ps < 0.05). No between-group changes were observed for any patient-reported outcomes. Relative dose intensity of exercise was lower in RT and CT compared with AT (Ps < 0.05). Conclusions In the context of a smaller than planned sample size, AT and CT significantly improved VO(2)peak in lung cancer survivors; however, the tolerability-to-benefit ratio was superior for AT and hence may be the preferred modality to target impaired CRF in post-treatment lung cancer survivors.
引用
收藏
页码:1456 / 1465
页数:10
相关论文
共 48 条
  • [1] American College of Sports Medicine, 2018, ACSMS GUID GRAD EX T, P226, DOI DOI 10.1136/BJSPORTS-2018-099836
  • [2] [Anonymous], 1999, AM J RESP CRIT CARE, V159, pS1
  • [3] Physical Activity and Exercise in Lung Cancer Care: Will Promises Be Fulfilled?
    Avancini, Alice
    Sartori, Giulia
    Gkountakos, Anastasios
    Casali, Miriam
    Trestini, Ilaria
    Tregnago, Daniela
    Bria, Emilio
    Jones, Lee W.
    Milella, Michele
    Lanza, Massimo
    Pilotto, Sara
    [J]. ONCOLOGIST, 2020, 25 (03) : E555 - E569
  • [4] Clinician's Guide to Cardiopulmonary Exercise Testing in Adults A Scientific Statement From the American Heart Association
    Balady, Gary J.
    Arena, Ross
    Sietsema, Kathy
    Myers, Jonathan
    Coke, Lola
    Fletcher, Gerald F.
    Forman, Daniel
    Franklin, Barry
    Guazzi, Marco
    Gulati, Martha
    Keteyian, Steven J.
    Lavie, Carl J.
    Macko, Richard
    Mancini, Donna
    Milani, Richard V.
    [J]. CIRCULATION, 2010, 122 (02) : 191 - 225
  • [5] Aerobic and strength training in patients with chronic obstructive pulmonary disease
    Bernard, S
    Whittom, F
    LeBlanc, P
    Jobin, J
    Belleau, R
    Bérubé, C
    Carrier, G
    Maltais, F
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : 896 - 901
  • [6] Preoperative Maximum Oxygen Consumption Is Associated With Prognosis After Pulmonary Resection in Stage I Non-Small Cell Lung Cancer
    Brunelli, Alessandro
    Pompili, Cecilia
    Salati, Michele
    Refai, Majed
    Berardi, Rossana
    Mazzanti, Paola
    Tiberi, Michela
    [J]. ANNALS OF THORACIC SURGERY, 2014, 98 (01) : 238 - 242
  • [7] Effects and moderators of exercise on quality of life and physical function in patients with cancer: An individual patient data meta-analysis of 34 RCTs
    Buffart, Laurien M.
    Kalter, Joeri
    Sweegers, Maike G.
    Courneya, Kerry S.
    Newton, Robert U.
    Aaronson, Neil K.
    Jacobsen, Paul B.
    May, Anne M.
    Galvao, Daniel A.
    Chinapaw, Mai J.
    Steindorf, Karen
    Irwin, Melinda L.
    Stuiver, Martijn M.
    Hayes, Sandi
    Griffith, Kathleen A.
    Lucia, Alejandro
    Mesters, Ilse
    van Weert, Ellen
    Knoop, Hans
    Goedendorp, Martine M.
    Mutrie, Nanette
    Daley, Amanda J.
    McConnachie, Alex
    Bohus, Martin
    Thorsen, Lene
    Schulz, Karl-Heinz
    Short, Camille E.
    James, Erica L.
    Plotnikoff, Ron C.
    Arbane, Gill
    Schmidt, Martina E.
    Potthoff, Karin
    van Beurden, Marc
    Oldenburg, Hester S.
    Sonke, Gabe S.
    van Harten, Wim H.
    Garrod, Rachel
    Schmitz, Kathryn H.
    Winters-Stone, Kerri M.
    Velthuis, Miranda J.
    Taaffe, Dennis R.
    van Mechelen, Willem
    Kersten, Marie Jose
    Nollet, Frans
    Wenzel, Jennifer
    Wiskemann, Joachim
    Verdonck-de Leeuw, Irma M.
    Brug, Johannes
    [J]. CANCER TREATMENT REVIEWS, 2017, 52 : 91 - 104
  • [8] Buysse D J, 1989, Psychiatry Res, V28, P193
  • [9] RELIABILITY AND VALIDITY OF THE FUNCTIONAL ASSESSMENT OF CANCER-THERAPY - LUNG (FACT-L) QUALITY-OF-LIFE INSTRUMENT
    CELLA, DF
    BONOMI, AE
    LLOYD, SR
    TULSKY, DS
    KAPLAN, E
    BONOMI, P
    [J]. LUNG CANCER, 1995, 12 (03) : 199 - 220
  • [10] THE FUNCTIONAL ASSESSMENT OF CANCER-THERAPY SCALE - DEVELOPMENT AND VALIDATION OF THE GENERAL MEASURE
    CELLA, DF
    TULSKY, DS
    GRAY, G
    SARAFIAN, B
    LINN, E
    BONOMI, A
    SILBERMAN, M
    YELLEN, SB
    WINICOUR, P
    BRANNON, J
    ECKBERG, K
    LLOYD, S
    PURL, S
    BLENDOWSKI, C
    GOODMAN, M
    BARNICLE, M
    STEWART, I
    MCHALE, M
    BONOMI, P
    KAPLAN, E
    TAYLOR, S
    THOMAS, CR
    HARRIS, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (03) : 570 - 579